Fig. 2From: Efficacy and safety of triplet chemotherapy plus anti-EGFR agents in metastatic colorectal cancer: a systematic review and meta-analysisForest plot of ORR in mCRC patients treated with triplet chemotherapy plus an anti-EGFR. ORR, objective response rate; mCRC, metastasis colorectal cancerBack to article page